$EBS Emergent BioSolutions Inc. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Emergent BioSolutions Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Emergent BioSolutions Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Emergent BioSolutions Inc. for free.

CIK Number: 0001367644
IRS Number: 141902018
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: EBS
Company Address: 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG 20879
Phone number: 240-631-3200

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It offers specialty products for civilian and military populations that address accidental, intentional and naturally occurring public health threats. The firm's products include ACAM2000, BioThrax, Raxibacuma, Vaxchora, and VIGIV. Its business units include Vaccines and Anti-Infectives; Antibody Therapeutics; Devices; and Contract Development and Manufacturing. The company was founded by Fuad El-Hibri in May 1998 and is headquartered in Gaithersburg, MD.

Market Capitalization: $1.21B
Prev close: $29.35
Average Daily Volume: 498,308
Days Low: $28.81
Year Low: $24.47
Year High: $44.38

Emergent BioSolutions Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 11 2021EBSEmergent BioSoluti ...LINDAHL RICHARD SEVP, Chief Financia ...Payment of ExerciseF61.621,05464,94736,91938 K to 36.9 K (-2.78 %)
May 11 2021EBSEmergent BioSoluti ...Kramer RobertPresident and CEOPayment of ExerciseF61.62945,792163,053163.1 K to 163.1 K (-0.06 %)
May 11 2021EBSEmergent BioSoluti ...SULLIVAN LOUIS WDirectorOption ExerciseM18.6410,305192,0850
May 11 2021EBSEmergent BioSoluti ...SULLIVAN LOUIS WDirectorPayment of ExerciseF61.623,118192,13139,94543.1 K to 39.9 K (-7.24 %)
May 11 2021EBSEmergent BioSoluti ...SULLIVAN LOUIS WDirectorBuyM18.6410,305192,08543,06332.8 K to 43.1 K (+31.46 %)
Apr 01 2021EBSEmergent BioSoluti ...Kirk SeanEVP, Manufacturing ...Payment of ExerciseF0.00159017,77617.9 K to 17.8 K (-0.89 %)
Mar 08 2021EBSEmergent BioSoluti ...Bailey SueDirectorSellS92.378,168754,47824,42732.6 K to 24.4 K (-25.06 %)
Feb 26 2021EBSEmergent BioSoluti ...El-Hibri FuadChairmanOption ExerciseA0.0013,906013,906
Feb 26 2021EBSEmergent BioSoluti ...El-Hibri FuadChairmanOption ExerciseA93.4927,8082,599,77027,808
Feb 26 2021EBSEmergent BioSoluti ...Kramer RobertPresident and CEOOption ExerciseA93.4959,8985,599,86459,898
Feb 26 2021EBSEmergent BioSoluti ...Kramer RobertPresident and CEOPayment of ExerciseF97.1586083,549163,147164 K to 163.1 K (-0.52 %)
Feb 26 2021EBSEmergent BioSoluti ...Kramer RobertPresident and CEOPayment of ExerciseF97.151,716166,709164,007165.7 K to 164 K (-1.04 %)
Feb 26 2021EBSEmergent BioSoluti ...Kramer RobertPresident and CEOPayment of ExerciseF93.492,425226,713165,723168.1 K to 165.7 K (-1.44 %)
Feb 26 2021EBSEmergent BioSoluti ...Kramer RobertPresident and CEOGrantA0.0014,9750168,148153.2 K to 168.1 K (+9.78 %)
Feb 26 2021EBSEmergent BioSoluti ...Kramer RobertPresident and CEOGrantA0.0014,9750153,173138.2 K to 153.2 K (+10.84 %)

View all Emergent BioSolutions Inc. insider transactions.